Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Glutamine Synthetase ELISA Kit (AC3466)
Cat.#: ASET-2055
Specifications
Description Mouse Glutamine Synthetase ELISA Kit allows for the in vitro quantitative determination of mouse Glutamine Synthetase concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2142 Human BACE1 ELISA Kit (AC3553) Quantitative inquiry ASET-1746 Human TMPRSS4 ELISA Kit (AC3157) Quantitative inquiry ASET-1453 Human Neurofibromin ELISA Kit (AC2864) Quantitative inquiry ASET-2094 Mouse VMAT2 ELISA Kit (AC3505) Quantitative inquiry ASET-2184 Human NAV2 ELISA Kit (AC3595) Quantitative inquiry ASET-1696 Mouse Angiogenin ELISA Kit (AC3107) Quantitative inquiry ASET-1070 Human DLL1 ELISA Kit (AC2481) Quantitative inquiry ASET-1527 Mouse Neuropeptide Y ELISA Kit (AC2938) Quantitative inquiry ASET-1329 Human MC1-R ELISA Kit (AC2740) Quantitative inquiry ASET-1027 Mouse Gpi ELISA Kit (AC2438) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket